(Q34863092)

5 August 2017

1 reference

title

Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer (English)

1 reference

5 August 2017

1 reference

1 reference

Mark N Levine

1

1 reference

5 August 2017

1 June 2002

1 reference

5 August 2017

Cancer Treatment Reviews

1 reference

5 August 2017

28

1 reference

5 August 2017

3

1 reference

5 August 2017

145-149

1 reference

Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.

5 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

Expanding eligibility for outpatient treatment of deep venous thrombosis and pulmonary embolism with low-molecular-weight heparin: a comparison of patient self-injection with homecare injection

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

A comparison of low-molecular-weight heparin with unfractionated heparin for acute pulmonary embolism. The THESEE Study Group. Tinzaparine ou Heparine Standard: Evaluations dans l'Embolie Pulmonaire

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

Venographic comparison of subcutaneous low-molecular weight heparin with oral anticoagulant therapy in the long-term treatment of deep venous thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0305-7372%2802%2900042-7

7 January 2021

10.1016/S0305-7372(02)00042-7

Identifiers

DOI

1 reference

release_uumwnu7gg5cfngsqgzx3s3266u

5 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/uumwnu7gg5cfngsqgzx3s3266u

24 November 2022

mapped directly with Wikidata item

PubMed ID

12234566

1 reference

PubMed ID

12234566